Own your medical & wearable data with Blockchain, opt-in to research, be incentivized" title="" class="btn" data-container="body" data-html="true" data-id="28738" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Embleema"> 2,210 449 3,737
Activities
Technologies
Entity types
Location
44 W 28th St, New York, NY 10001, USA
New York
United States of America
Employees
Scale: 11-50
Estimated: 24
Engaged corporates
9Added in Motherbase
5 years, 9 months agoEmbleema is the regulatory-grade health data platform to accelerate new drug discovery and release new treatments sooner
Embleema's software platform brings precision medicine sooner to patients by collecting and generating regulatory-grade evidence. Our platform natively unifies clinical, molecular and real-world data and is the sole one used by the FDA for its regulatory evaluation of health products involving genomic datasets. The protocols and algorithms contained in our platform are also the basis for future CDISC standards for cell and gene therapies. The FDA also uses our platform to produce regulatory grade genomic sequences for SARS-CoV-2 and other microbial pathogens (project ARGOS). In addition to the FDA, our platform powers the Lupus Landmark Study, the largest clinical study for lupus in the world, the Human Epilepsy Projects and tens of other clinical studies for pharmaceutical companies, biotechs and patient groups. More than half of the top 10 Investigational sites in the US use our platform: John Hopkins, NYU, UCSF, Yale, UPenn, Washington University in St Louis, Cornell and many others also such as Mayo Clinic, Yale, Georgetown.
Blockchain, Healthcare Technology, Electronic Medical Records, healthcare, Clinical Research, Clinical Trials, Medicine, Technology, Genomics, Bioinformatics, and Precision Medicine
Embleema’s platform accelerates observational research, connecting patients and researchers to advance precision medicine with seamless data collection and compliance.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Techstars Iowa Accelerator Startup accelerator & VC, Venture Capital & Private Equity | Techstars Iowa Accelerator Startup accelerator & VC, Venture Capital & Private Equity | Other 4 Oct 2019 | | |
Région Nouvelle-Aquitaine National and local authorities, Government Administration | Région Nouvelle-Aquitaine National and local authorities, Government Administration | Other 2 Jul 2019 | | |
Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 7 Nov 2018 | | |
STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Not capitalistic Not partnership Event 3 Oct 2018 | | |
Capgemini Consulting, IT Services and IT Consulting | Capgemini Consulting, IT Services and IT Consulting | Not capitalistic Partnership Event 20 Dec 2018 | | |
IBM IT services, IT Services and IT Consulting | IBM IT services, IT Services and IT Consulting | Other 26 Apr 2019 | | |
Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 4 Dec 2018 | | |
MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Event 8 Nov 2018 | | |
innov'a Non-profit Organizations | innov'a Non-profit Organizations | Other 12 Nov 2018 | |